| 000 | 01536 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250511205712.0 | ||
| 264 | 0 | _c19910827 | |
| 008 | 199108s 0 0 eng d | ||
| 022 | _a0891-6632 | ||
| 024 | 7 |
_a10.1016/0891-6632(91)90004-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMøller, A | |
| 245 | 0 | 0 |
_aLipoproteins and diuretics in type II diabetes. _h[electronic resource] |
| 260 |
_bThe Journal of diabetic complications _c |
||
| 300 |
_a13-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBenzothiadiazines |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 |
_aDiuretics _xadverse effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFurosemide _xadverse effects |
| 650 | 0 | 4 |
_aHeart Failure _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 |
_aLipoproteins _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPotassium _xblood |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSodium Chloride Symporter Inhibitors _xadverse effects |
| 700 | 1 | _aSchmitz, A | |
| 700 | 1 | _aPedersen, M M | |
| 700 | 1 | _aChristiansen, J S | |
| 773 | 0 |
_tThe Journal of diabetic complications _gvol. 5 _gno. 1 _gp. 13-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0891-6632(91)90004-9 _zAvailable from publisher's website |
| 999 |
_c1836527 _d1836527 |
||